Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Coronary

Complex PCI Sunday

Live Case from Baylor Scott & White - The Heart Hospital Plano | Plano, TX

Sunday, March 9, 2025
1:30 PM – 2:15 PM ET

    Live Case Operator(s)

  • Karim Al-Azizi, MD, FACC, FSCAI, FESC

    Medical Director, Cardiac Catheterization Laboratories
    The Heart Hospital, Baylor Scott & White Health Baylor Scott & White
    Frisco, Texas, United States

    Disclosure(s): Abbott Labs: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); shockwave: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Srini Potluri, MD

    Chief of Cardiology
    Baylor Scott and White The Heart Hospital Plano
    Frisco, Texas, United States

    Disclosure information not submitted.

  • ST

    Sibi Thomas, DO

    Baylor Scott and White The Heart Hospital Plano

    Disclosure information not submitted.

    • Moderator(s)

  • Lindsey Cilia, MD

    Co-Director of Complex Coronary Therapeutics Program Interventional Cardiologist
    Inova Heart and Vascular Institute/Virginia Heart
    Falls Church, Virginia, United States

    Disclosure(s): No financial relationships to disclose

  • Perwaiz M. Meraj, MD, FSCAI

    Director of Interventional Cardiology and Cardiac Catheterization Laboratory
    Northwell Health
    Manhasset, New York, United States

    Disclosure information not submitted.

  • Samin K. Sharma, MD

    Director, Mount Sinai Cardiovascular Clinical Institute
    Mount Sinai Hospital
    New York, New York, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • F. Aaysha Cader, MD MRCP MSc (Oxon)

    Cardiology Registrar
    Kettering General Hospital, UK
    Kettering, England, United Kingdom

    Disclosure(s): No financial relationships to disclose

  • Abdulla A. Damluji, MD, PhD, MBA

    Interventional Cardiologist
    Inova Heart and Vascular Institute
    Fairfax, Virginia, United States

    Disclosure information not submitted.

  • Ashequl M. Islam, MD

    Assoc Chief of Cardiology and Director of Valve Program and Interventional Cardiology Fellowship; Director, Heart and Vascular Program Strategy
    Baystate Medical Center
    Springfield, Massachusetts, United States

    Disclosure information not submitted.

  • David E. Kandzari, MD, FACC, FSCAI

    Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
    Piedmont Heart Institute
    Atlanta, Georgia, United States

    Disclosure information not submitted.

  • John M. Lasala, MD, PhD, MSCAI

    Professor of Medicine; Director, Structural Heart Disease Program
    Washington University School of Medicine
    St. Louis, Missouri, United States

    Disclosure(s): Abiomed;: Consultant (Ongoing); Boston Scietific: Consultant (Ongoing); Cordis Inc.: Consultant (Ongoing); Edwards, Abbott: Consultant (Ongoing); Shockwave Medical, Inc.: Consultant (Ongoing); W. L. Gore: Consultant (Ongoing)

  • Hady Lichaa, MD

    Interventional Cardiovascular Specialist
    Ascension Saint Thomas Hospital
    Murfreesboro, Tennessee, United States

    Disclosure(s): Abbott Vascular, Abiomed, Philips, Penumbra, shockwave and Medtronic.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Rajesh Sachdeva, MD, FACC, FSCAI

    Staff Physician
    Atlanta VA Medical Center, Georgia, United States

    Disclosure(s): No financial relationships to disclose

  • Fayaz Shawl, MD, FACC, FACP, FSCAI

    Director, Interventional Cardiology
    Adventist HeathCare WhiteOak Medical Center
    Silver Spring , Maryland, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Karim Al-Azizi, MD, FACC, FSCAI, FESC: Abbott Labs: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); shockwave: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Lindsey Cilia, MD: No financial relationships to disclose
Amir Kaki, MD, FACC, FSCAI: Abiomed Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
F. Aaysha Cader, MD MRCP MSc (Oxon): No financial relationships to disclose
John M. Lasala, MD, PhD, MSCAI: Abiomed;: Consultant (Ongoing); Boston Scietific: Consultant (Ongoing); Cordis Inc.: Consultant (Ongoing); Edwards, Abbott: Consultant (Ongoing); Shockwave Medical, Inc.: Consultant (Ongoing); W. L. Gore: Consultant (Ongoing)
Hady Lichaa, MD: Abbott Vascular, Abiomed, Philips, Penumbra, shockwave and Medtronic.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Rajesh Sachdeva, MD: No financial relationships to disclose
Fayaz Shawl, MD, FACC, FACP, FSCAI: No financial relationships to disclose